SCEMBLIX

novartis pharmaceuticals canada inc🇨🇦 Health Canada

Approval Id: af9d9d79a82ece77
Drug Approval Canada Name: SCEMBLIX
Product Name: SCEMBLIX
Status: Marketed
Status Date: 2022-09-01
Original Market Date: 2022-09-01
Din: 02528339
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01EA06 ASCIMINIB
Atc Name: l 01 ea 06
Aig Number: 0163861002
Company Name: novartis pharmaceuticals canada inc
Company Address: 100, 700 Rue Saint-Hubert, Montreal, Quebec, Canada, H2Y 0C1

ASCIMINIB (ASCIMINIB HYDROCHLORIDE)

40 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

af9d9d79a82ece77

Type

Standard